Revenue
2018
2019
2020
2021
2022
2023
2024
DNA X, Inc. (SONM)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $50.9M | $93.6M | $69.8M | $54.6M | $64.0M | $116.3M | $135.7M |
| Gross profit | — | $9.9M | $19.3M | $11.6M | $6.4M | $15.2M | $34.5M | $48.1M |
| Research & development | — | $14.2M | $1.8M | $8.0M | $17.7M | $16.2M | $26.1M | $23.2M |
| Operating expenses | $5.4M | $3.1M | $18.8M | $25.9M | $44.4M | $44.5M | $56.9M | $42.7M |
| Operating income | −$5.4M | −$3.1M | $513,000 | −$14.3M | −$38.0M | −$29.3M | −$22.4M | $5.4M |
| EBITDAderived | −$1.1M | $457,000 | $2.7M | −$11.9M | −$35.9M | −$26.5M | −$18.9M | $7.2M |
| Net income | −$20.7M | −$33.6M | −$90,000 | −$14.1M | −$38.6M | −$29.9M | −$25.8M | $1.3M |
| Basic EPSper diluted share | -$28.58 | -$128.37 | -$0.02 | -$0.49 | -$4.08 | -$6.48 | -$1.39 | -$2.57 |
| Diluted EPSper diluted share | -$28.58 | -$128.37 | -$0.02 | -$0.49 | -$4.08 | -$6.48 | -$1.39 | -$2.57 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 30, 2025Form 4 | LYTTON LAURENCE WTenPercentOwner | SellCommon Stock | 400.5K | $1.39 | $556.7K | 0 |
| Jun 26, 2025Form 4 | LYTTON LAURENCE WTenPercentOwner | SellCommon Stock | 466.4K | $1.50 | $699.6K | 400.5K |
| Apr 23, 2025Form 4 | Wang JeffreyDirector | SellCommon Stock | 4.5K | $1.45 | $6.5K | 21.3K |
| Apr 23, 2025Form 4 | Steenstra JackDirector | SellCommon Stock | 23.4K | $1.45 | $33.9K | 49.1K |
| Apr 23, 2025Form 4 | MULICA MICHAEL CDirector | SellCommon Stock | 27.8K | $1.45 | $40.3K | 73.3K |